RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: A randomised, phase 2 non-inferiority double-blind controlled trial

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: A randomised, phase 2 non-inferiority double-blind controlled trial

Add to Collection
RCTs MF Cotton, SA Madhi, AK Luabeya… - The Lancet Infectious …, 2022 - thelancet.com

Chapter : Section15
Journal Year : 2022
Cited by : 19

… vaccine. Seven (2%) of 312 participants in the VPM1002 group had a grade 3–4 vaccine-… and were free from active tuberculosis disease and diabetes. For the HIV unexposed group, …..... Read More

Keywords : ['randomised phase noninferiority doubleblind control trial', 'south african newborn baby', 'versus bcg', 'safety', 'immunogenicity']
PubMed Link : https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00222-5/fulltext
Google Scholar Link : https://scholar.google.com/scholar?cites=4370388900177452093&as_sdt=5,39&sciodt=0,39&hl=en&num=20